Oct 8 (Reuters) - Briacell Therapeutics Corp BCT.V :
* Successfully advances towards initiation of Briavax(TM) phase i/iia clinical
trial
* Says has submitted to the US food and drug administration final positive
results its first lot of briavax
* Says anticipate receiving approval to initiate the clinical trial by October
31
* Source text for Eikon ID:nMKWbMpnSa
* Further company coverage BCT.V